113 related articles for article (PubMed ID: 18528189)
21. Visualization of discrete sacral foramina as an ancillary sign of superscan.
Harshman LK; Latifi HR; Griffeth LK
Clin Nucl Med; 2011 Jan; 36(1):21-4. PubMed ID: 21157202
[TBL] [Abstract][Full Text] [Related]
22. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting.
Koizumi M; Wagatsuma K; Miyaji N; Murata T; Miwa K; Takiguchi T; Makino T; Koyama M
Ann Nucl Med; 2015 Feb; 29(2):138-48. PubMed ID: 25326907
[TBL] [Abstract][Full Text] [Related]
24. Bone metastasis classification using whole body images from prostate cancer patients based on convolutional neural networks application.
Papandrianos N; Papageorgiou E; Anagnostis A; Papageorgiou K
PLoS One; 2020; 15(8):e0237213. PubMed ID: 32797099
[TBL] [Abstract][Full Text] [Related]
25. Computer-assisted interpretation of planar whole-body bone scintigraphy in patients with newly diagnosed prostate cancer.
Petersen LJ; Mortensen JC; Bertelsen H; Zacho HD
Nucl Med Commun; 2015 Jul; 36(7):679-85. PubMed ID: 25757196
[TBL] [Abstract][Full Text] [Related]
26. Skeletal Metastases Presenting as Superscan on Technetium 99m Methylene Diphosphonate Whole Body Bone Scintigraphy in Different Type of Cancers: A 5-Year Retro-prospective Study.
Manohar PR; Rather TA; Khan SH; Malik D
World J Nucl Med; 2017; 16(1):39-44. PubMed ID: 28217018
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of a quantitative diagnostic sacroiliac bone scan index in cases of chronic low back pain in young male adults].
Zafeirakis A; Kasimos D; Sioka C; Aravanis I; Zoumboulidis A
Hell J Nucl Med; 2005; 8(1):19-26. PubMed ID: 15886747
[TBL] [Abstract][Full Text] [Related]
28. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract][Full Text] [Related]
29. A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition.
Anand A; Morris MJ; Kaboteh R; Reza M; Trägårdh E; Matsunaga N; Edenbrandt L; Bjartell A; Larson SM; Minarik D
J Nucl Med; 2016 Dec; 57(12):1865-1871. PubMed ID: 27445289
[TBL] [Abstract][Full Text] [Related]
30. Expert System for Bone Scan Interpretation Improves Progression Assessment in Bone Metastatic Prostate Cancer.
Haupt F; Berding G; Namazian A; Wilke F; Böker A; Merseburger A; Geworski L; Kuczyk MA; Bengel FM; Peters I
Adv Ther; 2017 Apr; 34(4):986-994. PubMed ID: 28265811
[TBL] [Abstract][Full Text] [Related]
31. Clinical utility of temporal subtraction images in successive whole-body bone scans: evaluation in a prospective clinical study.
Shiraishi J; Appelbaum D; Pu Y; Engelmann R; Li Q; Doi K
J Digit Imaging; 2011 Aug; 24(4):680-7. PubMed ID: 20730471
[TBL] [Abstract][Full Text] [Related]
32. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
[TBL] [Abstract][Full Text] [Related]
33. Quantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinoma.
Sundkvist GM; Ahlgren L; Lilja B; Mattsson S
Nuklearmedizin; 1992 Oct; 31(5):178-81. PubMed ID: 1465355
[TBL] [Abstract][Full Text] [Related]
34. The value of simultaneous co-registration of 99mTc- MDP and 131Iodine in metastatic differentiated thyroid carcinoma.
Kotb MH; Omar W; El-Maghraby T; El-Bedwihy M; El-Tawdy M; Mustafa H; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2007; 10(2):98-105. PubMed ID: 18228214
[TBL] [Abstract][Full Text] [Related]
35. Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer.
Nakajima K; Edenbrandt L; Mizokami A
Int J Urol; 2017 Sep; 24(9):668-673. PubMed ID: 28556293
[TBL] [Abstract][Full Text] [Related]
36. Examination of pattern of RI accumulation in thyroid cartilage on bone scintigraphy.
Kurooka H; Kawabe J; Tsumoto C; Hayashi T; Oe A; Kotani J; Higashiyama S; Kawamura E; Yamane H; Shiomi S
Ann Nucl Med; 2009 Jan; 23(1):43-8. PubMed ID: 19205837
[TBL] [Abstract][Full Text] [Related]
37. Feasibility and preliminary experience of quantitative T2* mapping at 3.0 T for detection and assessment of aggressiveness of prostate cancer.
Wu LM; Chen XX; Xuan HQ; Liu Q; Suo ST; Hu J; Xu JR
Acad Radiol; 2014 Aug; 21(8):1020-6. PubMed ID: 25018074
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a revised version of computer-assisted diagnosis system, BONENAVI version 2.1.7, for bone scintigraphy in cancer patients.
Koizumi M; Miyaji N; Murata T; Motegi K; Miwa K; Koyama M; Terauchi T; Wagatsuma K; Kawakami K; Richter J
Ann Nucl Med; 2015 Oct; 29(8):659-65. PubMed ID: 26033528
[TBL] [Abstract][Full Text] [Related]
39. The relationship between the serum prostate specific antigen and whole body scintigraphy in prostate cancer patients after prostatectomy.
Begic A; Kucukalic-Selimovic E; Obralic N; Duric O; Lacevic N; Begovic-Hadzimuratovic S; Skopljak A; Dzubur-Aganovic M
Med Arh; 2006; 60(1):54-5. PubMed ID: 16425536
[TBL] [Abstract][Full Text] [Related]
40. [Cancer of the prostate: value of bone scintigraphy. Point of view].
Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
